Skip to main content
. 2018 Feb 15;9(22):16087–16098. doi: 10.18632/oncotarget.24498

Table 4. Cox univariate and multivariate analyses for the validation dataset (n=62).

Variable Univariate Multivariate*
HR 95% CI P-value HR 95% CI P-value
18-GEP 4.61 1.89-11.23 0.0008 9.28 1.22-70.29 0.0311
WHO
 II vs. I 1.39 0.44-4.37 0.577 0.53 0.09-3.11 0.4857
Mitotic index**
 3-4 vs. ≤ 2 1.24 0.23-6.78 0.8034 0.74 0.05-10.70 0.8228
 ≥5 vs. ≤ 2 5.29 1.32-21.23 0.0187 24.67 3.40-179.06 0.0015
Simpson grade***
 2 vs. 1 3.62 0.66-19.76 0.1378 1.45 0.17-12.52 0.7364
 3 vs. 1 10.51 1.47-74.91 0.0189 2.96 0.08-107.56 0.5533
 4 vs. 1 5.11 0.93-27.90 0.0599 4.54 0.60-34.08 0.1416
Sex
 M vs. F 2.08 0.67-6.45 0.205 0.46 0.06-3.69 0.4619
Location
 Skull-base vs. Non skull-base 1.84 0.58-5.82 0.298 1.14 0.17-7.76 0.8971

* 55 cases with complete data across all variables were introduced in the model.

**58 cases with complete data were introduced in the univariate model.

***59 cases with complete data were introduced in the univariate model.

Legend: 18-GEP, 18 gene expression profile model; CI, confidence interval; F, female; HR, hazard ratio; M, male.